Operating Income (Loss) in USD of Autolus Therapeutics plc from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Autolus Therapeutics plc quarterly/annual Operating Income (Loss) history and change rate from 2017 to Q3 2025.
  • Autolus Therapeutics plc Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$71.6M, a 5.52% decline year-over-year.
  • Autolus Therapeutics plc Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$274M, a 25.2% decline year-over-year.
  • Autolus Therapeutics plc annual Operating Income (Loss) for 2024 was -$241M, a 34.3% decline from 2023.
  • Autolus Therapeutics plc annual Operating Income (Loss) for 2023 was -$180M, a 25.3% decline from 2022.
  • Autolus Therapeutics plc annual Operating Income (Loss) for 2022 was -$143M, a 1.67% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Autolus Therapeutics plc Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$274M -$71.6M -$3.75M -5.52% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 -$270M -$61.2M -$2.29M -3.88% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 -$268M -$65.2M -$26.5M -68.3% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$241M -$75.9M -$22.6M -42.4% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025
Q3 2024 -$219M -$67.9M -$25M -58.2% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 -$194M -$58.9M -$14.6M -32.8% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 -$179M -$38.8M +$391K +1% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$180M -$53.3M -$22.5M -72.9% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025
Q3 2023 -$157M -$42.9M -$5.56M -14.9% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$152M -$44.4M -$5.31M -13.6% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$146M -$39.1M -$2.96M -8.19% 01 Jan 2023 31 Mar 2023 10-Q 17 May 2024
Q4 2022 -$143M -$30.8M 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 -$37.3M 01 Jul 2022 30 Sep 2022 10-K 21 Mar 2024
Q2 2022 -$39.1M 01 Apr 2022 30 Jun 2022 10-K 21 Mar 2024
Q1 2022 -$36.2M +$3.69M +9.25% 01 Jan 2022 31 Mar 2022 10-K 21 Mar 2024
Q1 2021 -$169M -$39.9M -$1.31M -3.39% 01 Jan 2021 31 Mar 2021 6-K 06 May 2021
Q4 2020 -$168M -$47.3M -$4.25M -9.86% 01 Oct 2020 31 Dec 2020 20-F 07 Mar 2023
Q3 2020 -$164M -$42.7M -$7.09M -19.9% 01 Jul 2020 30 Sep 2020 6-K 05 Nov 2020
Q2 2020 -$157M -$39.5M -$2.34M -6.29% 01 Apr 2020 30 Jun 2020 6-K 06 Aug 2020
Q1 2020 -$154M -$38.6M -$8.41M -27.9% 01 Jan 2020 31 Mar 2020 6-K 06 May 2021
Q4 2019 -$146M -$43.1M -$18.1M -72.3% 01 Oct 2019 31 Dec 2019 20-F 10 Mar 2022
Q3 2019 -$128M -$35.6M 01 Jul 2019 30 Sep 2019 6-K 05 Nov 2020
Q2 2019 -$37.2M 01 Apr 2019 30 Jun 2019 6-K 06 Aug 2020
Q1 2019 -$30.2M 01 Jan 2019 31 Mar 2019 6-K 07 May 2020
Q4 2018 -$25M 01 Oct 2018 31 Dec 2018 20-F 04 Mar 2021

Autolus Therapeutics plc Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$241M -$61.7M -34.3% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025
2023 -$180M -$36.3M -25.3% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025
2022 -$143M -$2.36M -1.67% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 -$141M +$27.1M +16.1% 01 Jan 2021 31 Dec 2021 10-K 21 Mar 2024
2020 -$168M -$22.1M -15.1% 01 Jan 2020 31 Dec 2020 20-F 07 Mar 2023
2019 -$146M -$88.5M -154% 01 Jan 2019 31 Dec 2019 20-F 10 Mar 2022
2018 -$57.5M -$34.1M -146% 01 Oct 2017 30 Sep 2018 20-F 03 Mar 2020
2017 -$23.4M 01 Oct 2016 30 Sep 2017 20-F 03 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.